• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InsuLine Medical Ltd

+ Add to Watchlist


60.80 ILs 0.20 0.33%

As of 09:24:10 ET on 12/21/2014.

Snapshot for InsuLine Medical Ltd (INSL)

Open: 61.00 Day's Range: 60.20 - 61.90 Volume: 676,954
Previous Close: 61.00 52wk Range: 57.00 - 288.80 1-Yr Rtn: -76.74%

Stock Chart for INSL

No chart data available.
  • INSL:IT 60.50
  • 1D
  • 1M
  • 1Y
Interactive INSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.3700
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 75.03
Shares Outstanding (M) 123.41
30 Day Average Volume 463,547
Price/Book (mrq) 3.9631
Price/Sale (ttm) 110.1306
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSL

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for INSL

InsuLine Medical Ltd. researches medical devices for diabetes care. The Company researches devices to overcome the delay between meal glucose increase and the relatively slow absorbtion of subcutaneously injected insulin. InsuLine is researching a patch for use with infusion pumps, and a pad for use with insulin injections.

Ilan CohenChairman-Supervisory BdRon Ezra NagarCEO/Founder/President
Gabriel BittonVP:Research & DevelopmentNoam KfirVP:Operations & Manufacturing
More Company Profile & Key Executives for INSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil